Robert Gizicki MDCM, FRCSC, DABO
Dr Gizicki received his medical degree from McGill University and completed his residency in ophthalmology at the Université de Montréal, Québec. He then went on to complete a 2-year sub-specialty training in vitreo-retinal diseases and surgery at St Michael’s Hospital, University of Toronto, Canada. He then joined the retina group at Retina Surgical Associates and the Department of Ophthalmology at the University of British Columbia.
His interests are diverse and include retinal detachment repair, diabetic retinopathy treatment, complications of cataract surgery, and surgical performance analysis and benchmarking. He leads the clinical research program at Retina Surgical Associates, where he is the site principal investigator for multiple phase 3 and 4 clinical trials.
He is board-certified with the Royal College of Surgeons and Physicians of Canada as well as with the American Board of Ophthalmology. He is a member of many professional societies including the Canadian Ophthalmological Society, Canadian Retina Society, and the American Society of Retina Specialists.
Financial disclosure: Dr Gizicki has/had an affiliation (financial or otherwise) with a commercial organization:
- Roche
- Bayer
- Astellas
- Alcon
- Regenxbio
Sessions in which Robert Gizicki MDCM, FRCSC, DABO participates
Friday 16 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Understand the concept of retinal displacement in retinal detachment repair and the various factors affecting itAssess the use of multi-modal imaging technologies to optimize surgical resultsIntegrate peripheral retinal imaging in the assessment of retinal pathologiesCanMEDS Roles:
Saturday 17 June, 2023
Learning Objectives:At the end of this session, participants will be able to:Elucidate the cause and mechanism of DVD.Identity indications of Light adjustable lensXX
Sessions in which Robert Gizicki MDCM, FRCSC, DABO attends
Friday 16 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Assess new therapeutic modalities for dry age-related macular degenerationAssess current therapies for wet age-related macular degenerationAssess complications of anti-VGF treatments and preventative measuresCanMEDS Roles: Medical Expert, Scholar
Learning Objectives: At the end of this session, participants will be able to: Assess the use of multi-modal imaging in assessing retinal pathologyAssess new technologies in imaging of the retinaIntegrate new management strategies for diabetic retinopathyCanMEDS Roles: Medical Expert, Scholar
Saturday 17 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Identify Imaging Signs & Biomarkers for ongoing anti-VEGF treatmentIdentify and review pathognomonic imaging features of Inherited Retinal DiseaseReview unique retinal imaging findings in uncommon retinal conditions
Learning Objectives:At the end of this session, participants will be able to: To review pathophysiology of and novel treatments for Fuchs corneal dystrophyTo understand the effects of glaucoma on corneal transplantation success ratesTo understand various surgical techniques to treat ocular surface diseasesTo review endothelial transplantation techniques and outcomes in complex anterior segments&nb...